+
Site Tour
AMPLATZER™ DUCT OCCLUDERS
STRUCTURAL INTERVENTIONS

 

Designed for flexibility, our innovative duct occluder options conform to a variety of duct sizes while achieving complete patent ductus arteriosus (PDA) closure from a pulmonary or aortic approach.

SWITCH TO THE REFERRAL VIEW    For more information specific to neonatology regarding PDA closure

AMPLATZER™ DUCT OCCLUDER II:
VERSATILITY TO CONFORM TO A VARIETY OF PDAs

The Amplatzer™ Duct Occluder II is engineered using 2 articulating discs and multi-layered mesh that conforms to most classifications of PDAs.

Features include:

  • Symmetrical design so it can be introduced via pulmonary or aortic approach8
  • 6 planes of occlusion for full, cross-sectional coverage9
  • Fabric-free design allows for delivery through a low-profile catheter—while still achieving a very high occlusion rate8

Treatment range:

  • Ductus diameter: 2.5–5.5 mm
  • Ductus length: ≥ 5.0–12.0 mm


NEW VERSION AVAILABLE
GET THE AMPLATZER™ PORTFOLIO APP

The Amplatzer™ Portfolio App helps physicians determine which Amplatzer Structural Interventions device to use by suggesting applicable devices based on respective Instructions for Use.

Connext
TV

CONNECT TO THE LATEST
IN STRUCTURAL HEART
THERAPY

Find out more

References
  1. Data on file at Abbott.
  2. Philip R, Waller BR III, Agrawal V et al. Morphologic characterization of the patent ductus arteriosus in the premature infant and the choice of transcatheter occlusion device. Catheter Cardiovasc Interv. 2016;87(2): 310–317. doi.org/10.1002/ccd.26287.
  3. Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation. 2006;114(17):1873-1882. doi.org/10.1161/CIRCULATIONAHA.105.592063.
  4. Amplatzer Piccolo™ Occluder Instructions for Use.
  5. Stout KK, Daniels CJ, Aboulhosn JA et al. 2018 AHA/ACC Guideline for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(14):e698–e800. doi.org/10.1161/CIR.0000000000000603.
  6. Baruteau A-E, Hascoët S, Baruteau J et al. Transcatheter closure of patent ductus arteriosus: past, present and future. Arch Cardiovasc Dis. 2014;107(2):122–132.
    doi.org/10.1016/j.acvd.2014.01.008.
  7. Data on File, 302350-001_G Amplatzer™ Duct Occluder CER.
  8. Saliba Z, El-Rassi I, Abi-Warde MT et al. The Amplatzer Duct Occluder II: a new device for percutaneous ductus arteriosus closure. J Interven Cardiol. 2009;22(6):496–502.
    doi.org/10.1111/j.1540-8183.2009.00504.x.
  9. Gruenstein DH, et al. Transcatheter closure of patent ductus arteriosus using the Amplatzer™ Duct Occluder II (ADO II). Catheter Cardiovasc Interv. 2017;89(6):1118-1128. doi.org/10.1002/ccd.26968.

© Abbott 2024. All rights reserved.9-EH-5-14531-01 05-2024 REV A

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline